Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[zj3001]

I might play the bear every once and awhile, but it’s so easy to scare on low volume to get cheap shares.

The call from Company said they were in talks with many USA partners. We will see. The smarter move would be to just sell off consensi for $500m and focus on nt-219. Then finds other drugs to push through fda. That has been the vision of the company since day one. They are fda approval “experts” and combo drugs are their things.